Tagged with Intellectual Property

Interview: Dr. Boonchai Somboonsook, Secretary General of the Thai FDA and Mrs. Yuppadee Javroongrit, Senior Expert on Pharmaceuticals Standard, Food & Drug Administration, Thailand

government Interview: Dr. Boonchai Somboonsook, Secretary General of the Thai FDA and Mrs. Yuppadee Javroongrit, Senior Expert on Pharmaceuticals Standard, Food & Drug Administration, Thailand

government PharmaBoardroom met the Secretary General of the Thai FDA and the Senior Expert on Pharmaceutical Standards at the FDA. They explained the FDA’s role in Thailand’s pharma market, what the organization is doing for Thai copyright rights, how it is promoting international investment and integration within the ASEAN Economic Community. Please introduce…

Berken IP – Alicia Alvarez Berkenwald, Managing Partner and Patent Analyst – Argentina

IP Berken IP – Alicia Alvarez Berkenwald, Managing Partner and Patent Analyst – Argentina

IP Alicia Alvarez Berkenwald, Partner at the specialized intellectual property services firm Berken IP, gives an introduction to the Argentinian IP environment, common strategies used to bypass obstacles, and Berken IP’s role in helping increase IP awareness in Argentinian research institutions. Could you give us an overview of the changes…

Intellectual Property Interview: Michael Seckler, General Manager, Ferring Canada

Intellectual Property Michael Seckler of Ferring Canada offers his input about the affiliate’s recent restructuring, as well as the challenges of Canada’s reimbursement and pricing schemes and the advantages of the company’s unique “built-in competitive IP”. What have been your initial impressions of the Canadian pharmaceutical market since you joined last October?…

GGD Interview: Alain Leclerc, Co-Managing Partner, Goudreau Gage Dubuc, Canada

GGD The co-managing partner of one of Canada’s leading IP law firms discusses the landscape for intellectual property in the pharmaceutical industry in Canada today, the legislative challenges facing his clients, and the incentive schemes in place to bring innovation to Canada. What have you seen as the key trends of…

Biotechnology Interview: Roberto Bellini, President & CEO, Bellus Health, Canada

Biotechnology The CEO of Bellus Health outlines his strategy since 2010 to change the focus of the company from Alzheimer’s to a niche disease, AA amyloidosis, as well as the strategic shift towards becoming a semi-virtual model company. He also considers the importance of creating global links to capital as a…

Taiwan Intellectual property Office Interview with Mei-Hua Wang, , Taiwan Intellectual Property Office

Taiwan Intellectual property Office Please explain the factors that led to the creation of the Taiwan Intellectual Property Office, and its main activities today. For the Taiwanese government, intellectual property (IP) rights are very important, as they are one of the key factors to attracting foreign investment. As a result, for a number of…

1 2